(*) CA Approval Date: 2017. 12.04.
(*) EU Approval Date: 2017. 08.25
(*) USA Approval Date: 2019. 03.29.
>Cladribine Tablets
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2019. 03.26.
RRMS: Relapsing-Remitting MS
SPMS: Secondary Progressive MS
TradeMark
TradeMark Web-Site